Unravelling Toxoplasma treatment: conventional drugs toward nanomedicine
- 10 February 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in World Journal of Microbiology and Biotechnology
- Vol. 37 (3), 1-9
- https://doi.org/10.1007/s11274-021-03000-x
Abstract
Toxoplasma gondii is a worldwide protozoan parasite that infects almost all warm-blooded animals. Although human toxoplasmosis is mostly latent, pregnant women and immunocompromised patients need effective treatment. There are drugs of choice for treatment of toxoplasmosis; however, due to their side effects and/or their disease stage-specificity, prescription of them is limited. During recent years, nanomedicine has been employed to overcome limitations of conventional drugs. Here, we provided a state-of-the-art review of experimental toxoplasmosis treatment using nanotechnology. Graphic abstractKeywords
This publication has 63 references indexed in Scilit:
- The global burden of congenital toxoplasmosis: a systematic reviewBulletin of the World Health Organization, 2013
- Recent advances of chitosan nanoparticles as drug carriersInternational Journal of Nanomedicine, 2011
- Toxoplasmosis of Animals and Humans, Second Edition J.P Dubey . 6000 Broken Sound Parkway NW, Suite 300, Boca Raton, Florida 33487-2742. CRC Press, Taylor and Francis Group. ISBN: ISBN 978-1-4200-9236-3 (Hardback). 313 p.Journal of Parasitology, 2010
- SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood–brain barriersJournal of Drug Targeting, 2010
- A review of the antimicrobial activity of chitosanPolímeros, 2009
- Unique Cellular Interaction of Silver Nanoparticles: Size-Dependent Generation of Reactive Oxygen SpeciesThe Journal of Physical Chemistry B, 2008
- Clinical Practice: Management ofToxoplasma gondiiInfection during PregnancyClinical Infectious Diseases, 2008
- SEVERE SULFADIAZINE HYPERSENSITIVITY IN A CHILD WITH REACTIVATED CONGENITAL TOXOPLASMIC CHORIORETINITISThe Pediatric Infectious Disease Journal, 2006
- Toxoplasmic Chorioretinitis in the Setting of Acute Acquired ToxoplasmosisClinical Infectious Diseases, 1996
- Silver ion (Ag+)-Induced increases in cell membrane K+ and Na+ permeability in the renal proximal tubule: Reversal by thiol reagentsThe Journal of Membrane Biology, 1988